Sign In
Buy PFE
$26.04
+0.345 (+1.34%)
At Close: Jun 05, 2026
Pfizer Vs. Eli Lilly Stock – Which Is A Better Pick?
09:30am, Thursday, 11'th Jul 2024
We believe that Eli Lilly stock (NYSE: LLY) is currently a better pick than its industry peer – Pfizer stock , given its better prospects. PFE stock trades at a much lower multiple of 2.8x revenues,
7 High-Yield Dividend Stocks to Buy and Hold Forever: July Edition
08:00am, Thursday, 11'th Jul 2024
Seven companies offer a safety net against market volatility and constant dividend payments for those looking for a stable source of income. High-yield dividend companies are particularly appealing in
Pfizer Moves Forward With Weight-Loss Pill. The Stock Is Rising.
07:42am, Thursday, 11'th Jul 2024
Pfizer is advancing the development of its once-daily weight loss pill, danuglipron.
Pfizer advances development of once-daily formulation of oral weight loss pill
07:41am, Thursday, 11'th Jul 2024
CNBC's Angelica Peebles joins 'Squawk Box' with the latest news from Pfizer.
Pfizer says it has identified and selected a preferred formulation for its one-a-day obesity pill
07:22am, Thursday, 11'th Jul 2024
Pfizer Inc.'s stock PFE rose 2.4% early Thursday, after the drug company said it has identified and selected a formulation for its once-daily pill to treat obesity. “Obesity is a key therapeutic are
CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech
07:15am, Thursday, 11'th Jul 2024
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) sc
Pfizer moves forward with once-daily version of weight loss pill after setbacks
06:57am, Thursday, 11'th Jul 2024
Pfizer said it will continue to develop the once-daily version of its weight loss pill, danuglipron, after it saw "encouraging" data in an early-stage trial. The company plans to conduct studies in th
Pfizer moves forward with once-daily weight loss pill
06:54am, Thursday, 11'th Jul 2024
Pfizer said on Thursday it would advance a reworked, once-a-day version of its experimental obesity pill, danuglipron to clinical trials in the second half of this year, sending its shares 5% higher i
Pfizer Advances Development of Once-Daily Formulation of Oral GLP-1 Receptor Agonist Danuglipron
06:45am, Thursday, 11'th Jul 2024
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that based on results from the ongoing pharmacokinetic study (NCT06153758), the company has selected its preferred once-daily modifie
3 High-Dividend Stocks to Buy if You Are Seeking Consistent Payouts
06:45am, Thursday, 11'th Jul 2024
One reason to invest in stocks is to generate a stable income that can help finance your life without having to work all the time. This includes investing in high-dividend stocks.
7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns
03:22pm, Wednesday, 10'th Jul 2024
In my view, it's important for every individual to invest in equities. By just holding cash in a back account, there is bound to be loss of purchasing power when adjusted for inflation.
3 No-Brainer Stocks to Buy With $100 Right Now
04:51am, Wednesday, 10'th Jul 2024
Any time can represent the ideal moment to put your money to work on Wall Street when you're a long-term investor. Most brokers have eliminated minimum deposit requirements and commission fees, making
Evotec and Pfizer Collaborate to Advance Drug Discovery in France
01:50am, Wednesday, 10'th Jul 2024
Multi-year collaboration will initially focus on early discovery research for metabolic and infectious diseases HAMBURG, GERMANY / ACCESSWIRE / July 10, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)
The 3 Most Undervalued Large-Cap Stocks to Buy in July 2024
01:02pm, Tuesday, 09'th Jul 2024
There's a popular perception that investors have to look at smaller companies to find the biggest gains. And, sure, there is a grain of truth to the underlying sentiment.
Pfizer: Buy This Big Yielder On The Strong Pipeline
07:44am, Tuesday, 09'th Jul 2024
Pfizer's cash flow from operations in 2022 was $29.267 billion, driven by COVID-19 vaccine and Paxlovid sales, but dropped to $8.7 billion in 2023. Despite revenue loss from COVID-19 drugs, the Compan
